COVID-19 Related Content
European Commission approves second Moderna contract for 300m vaccines
The European Commission has approved a second contract with Moderna to secure an additional 300 million vaccine doses.
COVID-19: Surge in the use of NHS tech in 2020
Ben Davison, NHS Digital’s Executive Director for Product Development, explains how the coronavirus pandemic prompts a surge in the number of people using NHS tech in 2020.
Is the UK heading for a “perfect storm” of diabetes referrals?
Here, a leading clinical negligence specialist warns the UK may be heading for a “perfect storm” of diabetes complications, due to delayed COVID-19 referrals.
Can pubs effectively prevent COVID-19 transmission risk?
A new study has questioned whether pub operators can effectively and consistently prevent COVID-19 transmission risk.
New contraception guidelines for the COVID-19 pandemic
Dr Deborah Lee, Dr Fox Online Pharmacy, clarifies everything you need to know about using and accessing contraception during the COVID-19 pandemic.
How TECS have supported the NHS pre, during and post-COVID
Zillah Moore, Director at Tunstall Healthcare, discusses the role of technology-enabled care services and remote patient monitoring in reducing delayed discharge from hospitals and providing much-needed assistance to the NHS.
Heart failure drug may treat COVID-19 long-hauler symptom
Researchers have found that an existing heart failure drug can improve the symptoms associated with postural orthostatic tachycardia syndrome.
Managing debt collection in the wake of the pandemic
Brian Holden, Global Director of Financial Services at SAS UK & Ireland, explores the potential of the UK Government managing debt collection in the wake of the pandemic.
Covax will protect millions of Pakistanis against COVID-19
The global vaccine facility Covax will help Pakistan’s vaccination programme protect millions of Pakistanis against COVID-19.
Can COVID-19 affect the use of contraception?
Dr Deborah Lee, Dr Fox Online Pharmacy, discusses how the COVID-19 pandemic can affect the use of the pill, the contraceptive patch and the vaginal ring.
Tocilizumab reduces deaths in hospitalised COVID-19 patients
A new trial has found that tocilizumab, an anti-inflammatory treatment, reduces the risk of death in patients hospitalised with COVID-19.
How governments can build on the use of data and tech in fighting COVID-19
George Atalla, EY Global Government & Infrastructure Leader, explores the effect that COVID-19 has had on the use of data and technology in healthcare.
COVID-19 and drugs in the European neighbourhood partnership countries
The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.
COVID-19: The truth about super-spreaders
Dr Deborah Lee from Dr Fox Online Pharmacy, reveals the truth about super-spreaders as part of our focus on COVID-19.
Ensuring total infection control in 2021
Jackie Hook, Head Technical Chemist (CChem MRSC) at JLA Ltd underlines the importance of ensuring total infection control in 2021.
The impact of the COVID-19 pandemic on cancer treatment
Experts from the International Agency for Research on Cancer and the University of Molise chart the impact of the COVID-19 pandemic on cancer treatment.
Unpaid carers will have access to free PPE through national scheme
Unpaid carers will now benefit from free Personal Protective Equipment (PPE) through a new national scheme, the UK government has announced.
COVID-19: The challenge of healthcare logistics
Zisis Kozlakidis, International Agency for Research on Cancer, with Erik Steinfelder, Thermo Fisher Scientific, chart the challenges in healthcare logistics in relation to COVID-19.
UK Government and CureVac partnership to tackle COVID-19 virus variants
The UK Government and vaccine manufacturer CureVac have partnered to rapidly develop new vaccines in response to new COVID-19 virus variants.
UK regulator assures safety of COVID-19 vaccines
Recent data published by the UK’s independent medicines regulator assures the Pfizer/BioNTech and the Oxford University/AstraZeneca vaccines meet strict regulatory standards for safety
